Showing 4,501 - 4,520 results of 21,772 for search 'Laon~', query time: 1.21s Refine Results
  1. 4501
  2. 4502
  3. 4503
  4. 4504
  5. 4505

    Prevention of Relapse in Reflux Esophagitis: A Placebo Controlled Study of Ranitidine 150 mg BID and 300 mg BID by John H Hegarty, Lars Halvorsen, Bouke P Hazenberg, Andrzej Nowak, Colin L Smith, Alan B Thomson, G Vantrappen, Ceri J Mckenna, Jane G Mills

    Published 1997-01-01
    “…OBJECTIVE: To compare the efficacy and safety of long term use of ranitidine 150 mg bid, 300 mg bid and placebo in prevention of endoscopic and symptomatic relapse of reflux esophagitis in an international, double-blind, placebo controlled, parallel group study.…”
    Get full text
    Article
  6. 4506

    Peer and lay health work for people experiencing homelessness: A scoping review. by Jessica Mangan, Pablo Del Cid Nunez, Sara Daou, Graziella El-Khechen Richandi, Amna Siddiqui, Jonathan Wong, Liz Birk-Urovitz, Andrew Bond, Aaron M Orkin

    Published 2024-01-01
    “…The scope and breadth of peer and lay health worker programs among PEH has not been synthesized. …”
    Get full text
    Article
  7. 4507

    Physiological and sanitary quality of soybean seeds in response to harvest delay by Carlos Henrique Conceição Sousa, Alan Mario Zuffo, Ricardo Mezzomo, Leandra Matos Barrozo, Fábio Steiner, Mohamed A. El-Tayeb, Hamada AbdElgawad, Charline Zaratin Alves

    Published 2025-01-01
    “…ABSTRACT Delays in soybean harvesting can limit seed viability and vigor. In this study, soybean cultivar seeds’ physiological and sanitary quality was evaluated in response to harvest delay. …”
    Get full text
    Article
  8. 4508

    Buprenorphine for Chronic Pain: A Safer Alternative to Traditional Opioids by Suhani Dalal, Ahish Chitneni, Amnon A. Berger, Vwaire Orhurhu, Bilal Dar, Bennett Kramer, Anvinh Nguyen, John Pruit, Charles Halsted, Alan D. Kaye, Jamal Hasoon

    Published 2021-08-01
    “…With the ongoing public health crisis with prescription opioids, there is a need for safer alternatives for medication management in chronic pain patients. Buprenorphine is a partial mu-opioid agonist which is commonly utilized to treat patients with opioid-use disorders. …”
    Get full text
    Article
  9. 4509

    Factores de Riesgo para Enfermedades Crónicas en Cienfuegos, Cuba 2010. Resultados preliminares de CARMEN II by Mikhail Benet Rodríguez, Alain Morejón Giraldon, Alfredo Dario Espinosa Brito, Orestes Orlando Landrove Rodríguez, Dania Peraza Alejo, Pedro Ovidio Orduñez García Ovidio Orduñez García

    Published 2017-01-01
    “…El objetivo de esta comunicación breve es describir la prevalencia de cuatro de los más importante factores de riesgo de estas enfermedades durante el primer corte que se hace de la segunda medición del proyecto CARMEN Cienfuegos, mostrándose también las diferencias con los resultados de la primera medición. …”
    Get full text
    Article
  10. 4510

    Chemoimmunotherapy as induction treatment in concurrent chemoradiotherapy for patients with nasopharyngeal carcinoma stage IVa by Kun-Peng Wu, Qing-Qing Li, Xu-Qiang Luo, Xiao-Xi Wang, Yan-Zhen Lai, Dan Tian, Hong-cheng Yang, Xue-Ling Wei, Lan-Ying Wang, Qiu-Ming Li, Dao Zhu, Si-Jie Chen, Yang-Si Li

    Published 2025-12-01
    “…Background Chemoimmunotherapy is the first-line therapy for patients with recurrent or metastatic nasopharyngeal carcinoma (NPC) and is currently the main induction treatment option for patients with locoregionally advanced NPC. …”
    Get full text
    Article
  11. 4511

    Coherent harmonic generation of magnons in spin textures by Guibin Lan, Kang-Yuan Liu, Zhenyu Wang, Fan Xia, Hongjun Xu, Tengyu Guo, Yu Zhang, Bin He, Jiahui Li, Caihua Wan, Gerrit E. W. Bauer, Peng Yan, Gang-Qin Liu, Xin-Yu Pan, Xiufeng Han, Guoqiang Yu

    Published 2025-01-01
    “…Abstract Harmonic generation, a notable non-linear phenomenon, has promising applications in information processing. …”
    Get full text
    Article
  12. 4512

    Anti-TROVE2 Antibody Determined by Immune-Related Array May Serve as a Predictive Marker for Adalimumab Immunogenicity and Effectiveness in RA by Po-Ku Chen, Joung-Liang Lan, Yi-Ming Chen, Hsin-Hua Chen, Shih-Hsin Chang, Chia-Min Chung, Nurul H. Rutt, Ti-Myen Tan, Raja Nurashirin Raja Mamat, Nur Diana Anuar, Jonathan M. Blackburn, Der-Yuan Chen

    Published 2021-01-01
    “…The biomarkers were identified for predicting ADAb development and therapeutic response using the immune-related microarray and machine learning approach. ADAb-positive patients had lower drug levels at week 24 (median=0.024 μg/ml) compared with ADAb-negative patients (median=6.38 μg/ml, p<0.001). …”
    Get full text
    Article
  13. 4513

    Combined prognostic value of the cancer stem cell markers CD47 and CD133 in esophageal squamous cell carcinoma by Jian‐Hua Wang, Shu‐Ting Huang, Lan Zhang, Zi‐Gang Liu, Rong‐Xin Liang, Sen‐Wei Jiang, Yi‐Nan Jiang, Xing‐Juan Yu, Yu‐Chuan Jiang, Xi‐Zhao Li, Pei‐Fen Zhang, Zhe‐Sheng Wen, Min Zheng

    Published 2019-03-01
    “…Results Results conclude that CD47 and CD133 expression is increased in tumor tissues as compared to adjacent non‐tumor tissues. A positive correlation between CD47/CD133 expression and differentiation was found in 136 ESCC patients. …”
    Get full text
    Article
  14. 4514
  15. 4515
  16. 4516
  17. 4517

    HER-SAFE study design: an open-label, randomised controlled trial to investigate the safety of withdrawal of pharmacological treatment for recovered HER2-targeted therapy-related c... by Robin Chung, James C Moon, Alexander R Lyon, Charlotte H Manisty, Muhummad Sohaib Nazir, Malcolm Walker, Peter Kellman, Benjamin Dowsing, Daniel Chen, Jessica Artico, Mark Westwood, Hakim-Moulay Dehbi, Rebecca Roylance, Tom Crake, Peter Schmid, Arjun Ghosh, Maria Sol Andres, Joanna Pedra, Orla Worn

    Published 2025-02-01
    “…The Randomised Controlled Trial for the Safety of Withdrawal of Pharmacological Treatment for Recovered HER2 Targeted Therapy Related Cardiac Dysfunction (HER-SAFE) aims to evaluate whether HFT can be safely withdrawn in non-high cardiovascular (CV) risk patients with ‘recovered’ HER2 CTRCD.Methods and analysis This is a multicentre, open-label randomised controlled trial investigating whether withdrawal of HFT is non-inferior to continuation in non-high CV risk, breast cancer survivors with recovered HER2 CTRCD after cancer treatment completion. …”
    Get full text
    Article
  18. 4518

    Lower Extremity Peripheral Arterial Disease Is an Independent Predictor of Coronary Heart Disease and Stroke Risks in Patients with Type 2 Diabetes Mellitus in China by Xiao-Hong Pang, Jue Han, Wan-Lan Ye, Xue Sun, Yue Ding, Wen-Juan Huang, Yi-Ming Zhao, Han-Yu Lou, Li-Zhen Shan, Ying-Xiu Kang, Xiao-Xiao Song, Song-Zhao Zhang, Wei Gu, Peng-Fei Shan

    Published 2017-01-01
    “…The patients were divided into a lower extremity PAD group (ankle-brachial index≤0.9 or >1.4; 88 patients, 7.5%) and a non-PAD group (ankle-brachial index>0.9 and ≤1.4; 1090 patients, 92.5%). …”
    Get full text
    Article
  19. 4519
  20. 4520

    The R203M and D377Y mutations of the nucleocapsid protein promote SARS-CoV-2 infectivity by impairing RIG-I-mediated antiviral signaling. by Yongkui Li, Moran Li, Heng Xiao, Feng Liao, Miaomiao Shen, Weiwei Ge, Junxian Ou, Yuqing Liu, Lumiao Chen, Yue Zhao, Pin Wan, Jinbiao Liu, Jun Chen, Xianwu Lan, Shaorong Wu, Qiang Ding, Geng Li, Qiwei Zhang, Pan Pan

    Published 2025-01-01
    “…The viral protein mutations can modify virus-host interactions during virus evolution, and thus alter the extent of infection or pathogenicity. …”
    Get full text
    Article